Japanese Healthcare System / 日本医疗体系

The Japanese healthcare system enters the wiki through vol.120.日本医疗体系的崩溃与重生：医院、药品、医保三角困局的一种解法 as an integrated hospital-drug-insurance arrangement rather than a single policy. The source argues that Japan’s relative stability after 1990s [[JapaneseMedicalCollapse|medical collapse]] came from moving several pieces together: Japanese Universal Health Coverage / 日本全民医保, High-Cost Medical Expense Benefit / 高额疗养制度, Lifestyle-Disease Prevention / 生活习惯病预防, Japanese Medical Triage System / 日本分诊制, Community Integrated Care / 社区综合照护, DPC/DRG Payment Reform, Japanese Drug Pricing Reform / 日本药品定价改革, Generic Drug Trust Rebuilding / 仿制药再信任, and Pharmacist As Second Doctor / 药剂师第二医生体系.

The source’s core value is comparative. [[DavidWeng|大卫翁]] reads Japan as a useful mirror for China because both face aging, public-insurance affordability, drug-price pressure, tiered diagnosis, community elder care, and heavy state involvement in medical finance.

Key Claims

• Healthcare supply has to include service capacity, drug supply, and insurance financing at the same time.
• Demand management is not only rationing; prevention, screening, chronic-disease support, and out-of-pocket caps also shape patient behavior.
• Japan’s answer was not one lever. Reform worked when insurance, hospital incentives, drug pricing, community care, and professional roles reinforced each other.
• The system trades away some direct access and emergency convenience in exchange for lower prices and more efficient ordinary care.

Connections

• Japan and China - country comparison frame.
• Japanese Medical Collapse / 日本医疗崩坏 - failure path the reform responded to.
• Japanese Universal Health Coverage / 日本全民医保, High-Cost Medical Expense Benefit / 高额疗养制度, and Health Insurance Planning - coverage and household-cost branch.
• Japanese Medical Triage System / 日本分诊制, Community Integrated Care / 社区综合照护, and Healthcare Impossible Triangle / 医疗不可能三角 - service-delivery branch.
• DPC/DRG Payment Reform, Japanese Drug Pricing Reform / 日本药品定价改革, Generic Drug Trust Rebuilding / 仿制药再信任, and Pharmacist As Second Doctor / 药剂师第二医生体系 - payment, drug, and professional-role branch.